11 studies found for:    12050336 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions
Conditions: Stable Angina;   Unstable Angina
Interventions: Device: Drug Coated Balloon;   Device: Bare Metal Stent
2 Recruiting French Observatory Evaluating the Use of Intracoronary Prosthesis ABSORB BVS
Condition: Intracoronary Angioplasty
Intervention:
3 Active, not recruiting A Study Comparing Two Stent on the Degree of Early Stent Healing and Late Lumen Loss.The OCT-ORION Study
Condition: Coronary Artery Disease
Interventions: Device: Resolute Integrity Stent;   Device: Biomatrix stent
4 Active, not recruiting e-NOBORI Observational Registry of Nobori DES
Condition: Coronary Artery Disease
Intervention:
5 Enrolling by invitation NIH Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
Condition: Coronary Restenosis
Intervention:
6 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
7 Unknown  Evaluation of a New Nanotechnology Based Drug-Eluting Stent for Opening of Narrowed Arteries of the Heart
Condition: Coronary Stenosis
Intervention: Device: drug eluting nonpolymeric nanoporous stent
8 Completed Rotational Atherectomy Prior to Taxus Stent
Condition: Complex Calcified Coronary Lesions
Interventions: Procedure: Rotational Atherectomy + PES;   Procedure: Standard Treatment (PES without Rotational Atherectomy)
9 Completed ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial
Condition: Coronary Occlusions
Intervention: Device: Cypher sirolimus eluting coronary stent
10 Completed The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
Condition: Coronary Disease
Interventions: Device: Rapamycin-eluting Stent;   Device: Zotarolimus-eluting Stent
11 Unknown  Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
Condition: Coronary Disease
Interventions: Device: 2% rapamycin-eluting YUKONdes PEARL-stent;   Device: 1% rapamycin-eluting YUKONdes PEARL-stent;   Device: YUKONdes PEARL-stent coated with placebo (ethanol)

Indicates status has not been verified in more than two years